Financials
Financial year 2025
MV Lifesciences from Rixensart, company number BE0781705776, closed financial year 2025 with a result of € 155,021 after tax. For that financial year MV Lifesciences recorded a gross margin of € 196,382 and equity of € 146,155. Compared with financial year 2024, the result moved from € 150,316 to € 155,021. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 146,155
▼ 43% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 155,021
▲ 3% vs 2024
Profit after tax over the fiscal year.
€ 27,474
▲ 14% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 265,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 1,673
▼ 58% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,550
▼ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 133,164
▲ 77% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 199,168 | € 213,161 | € 207,235 | € 196,382 | ▼ 5% |
| Profit after taxes | € 148,787 | € 160,603 | € 150,316 | € 155,021 | ▲ 3% |
| Equity | € 35,215 | € 195,818 | € 256,134 | € 146,155 | ▼ 43% |
| Total debts | € 197,066 | € 115,516 | € 79,371 | € 349,464 | ▲ € 270,093 |
| Cash | € 70,415 | € 67,787 | € 24,000 | € 27,474 | ▲ 14% |
| Retained profit | € 15,215 | € 175,818 | € 236,134 | € 126,155 | ▼ 47% |
| Dividend | € 133,572 | € 0 | € 90,000 | € 265,000 | ▲ 194% |
| Balance sheet total | € 232,281 | € 311,334 | € 335,505 | € 495,619 | ▲ 48% |
Key figures of MV Lifesciences, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MV Lifesciences?
What happened at MV Lifesciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 155,021 (▲ 3% vs 2024). filed late Source: NBB ↗
- New establishment in Rixensart. KBO
- Start of the company according to the CBE. KBO
In short
From € 148,787 profit in 2022 to € 155,021 profit in 2025.
Paid € 202,229 in corporate taxes since 2022.
Best year ever: 2023, with € 160,603 profit.
Paid out € 488,572 in dividends to the owners in total.
A new publication or filing at MV Lifesciences? We notify you, reason included.
Follow MV LifesciencesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MV Lifesciences is Michel Vanbrabant . Michel Vanbrabant is also behind ENDO TOOLS THERAPEUTICS and ISTAR MEDICAL.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue de Genval 22
1331 Rixensart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0781.705.776
- VAT number
- BE 0781.705.776
- Registered office
- Rue de Genval 22, 1331 Rixensart
- Names & denominations
- MV Lifesciences
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 February 2022
- Peppol
- Active · Active since 5 May 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Handelsbemiddeling in de groothandel in andere specifieke goederen
Activiteiten van holdings
Markt- en opinieonderzoek
Handel in eigen onroerend goed
Holdings